Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine, a ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

This phenomenon leads to the production of an excessive amount of another antibody, immunoglobulin G (IgG). Under normal conditions, "vaccines generate a response through pneumococcus-specific IgG ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause ...

Vet Claire Woodmartin from SES Equine Veterinary Services shares some common problems breeders may face with newborn foals.

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg ... all of whom had been treated with 2 g/kg of IVIg. Total IgG levels were determined in serum samples pretreatment ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Wildfire smoke exposure acutely increased IL-13 expression in NK cells and was negatively associated with COVID-19 vaccine immunity.

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

The company plans to use results from its Phase III myasthenia gravis study to support its pipeline candidate IMVT-1402 over ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia.